GlassScriptPhysician profile
Cecilia Stradtman
NPI 1134202401
$3,071.68
in general payments reported to CMS, 2019-2025
37 companies · $227 in 2025
The $227 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $644 · 2020: $360 · 2021: $415 · 2022: $520 · 2023: $599 · 2024: $307 · 2025: $227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,132.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $372.88 | 2019-2024 | |
| Abbvie INC. | $354.68 | 2019-2025 | Lo Loestrin Fe |
| Astellas Pharma US INC | $236.28 | 2019-2025 | Veozah |
| Amgen INC. | $198.64 | 2019-2023 | Prolia, Evenity |
| Organon LLC | $179.15 | 2022-2025 | Nexplanon, Jada System |
| Sumitomo Pharma America, INC. | $149.69 | 2023-2024 | Myfembree |
| Myovant Sciences INC. | $136.99 | 2021-2022 | |
| Therapeuticsmd, INC. | $112.79 | 2019-2022 | |
| Becton, Dickinson and Company | $106.02 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $103.62 | 2019-2025 | |
| Myriad Women'S Health, INC. | $96.88 | 2023 | Myrisk |
| Mayne Pharma Commercial LLC | $85.90 | 2021-2023 | |
| Evofem Biosciences, INC. | $85.04 | 2021-2022 | |
| Scynexis, INC. | $84.80 | 2021-2022 | |
| Coopersurgical, INC. | $84.11 | 2020-2025 | Endosee, Paragard T 380a, Paragard T 380a |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $80.95 | 2019-2023 | Slynd |
| Hologic Sales and Service, LLC | $70.90 | 2020-2025 | Aptima, Novasure, Myosure Tissue Removal Device |
| Ascend Therapeutics US, LLC | $57.74 | 2019 | |
| Duchesnay USA Incorporated | $50.68 | 2019 | |
| Minerva Surgical, INC | $48.60 | 2020-2024 | |
| Shield Therapeutics INC | $39.40 | 2023-2024 | Accrufer |
| Intuitive Surgical, INC. | $38.47 | 2024 | |
| Sage Therapeutics, LLC | $35.34 | 2020-2024 | |
| Millicent US INC | $35.18 | 2023 | Intrarosa |
| Merck Sharp & Dohme LLC | $28.72 | 2020-2023 | Gardasil 9 |
| Lupin INC. | $25.42 | 2020 | |
| Mylan Pharmaceuticals INC. | $23.16 | 2020-2022 | |
| Exact Sciences Corporation | $19.49 | 2023 | Cologuard Collection Kit |
| Agile Therapeutics, INC. | $18.53 | 2021 | |
| Vertical Pharmaceuticals, LLC | $17.63 | 2019 | |
| Daiichi Sankyo INC. | $16.08 | 2019 | |
| Urovant Sciences INC | $15.69 | 2022 | |
| Lilly USA, LLC | $15.30 | 2024 | Zepbound |
| Amag Pharmaceuticals, INC. | $14.03 | 2019 | |
| Meditrina | $11.30 | 2025 | |
| Glaxosmithkline, LLC. | $11.02 | 2020 | |
| Acessa Health INC. | $10.58 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cecilia Stradtman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.